The function of MEF2B mutation in DLBCL has not been definitively established24,25, and these putative inactivating mutations provides further evidence of its role as a tumour suppressor but does not eliminate the possibility of shortened isoforms with an enhanced or distinct activity. Here, MEF2B is linked to neoplasm.